文献速递血栓与止血

补体介导超大HIT免疫复合物的结合与促凝效应

Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes.
PubMed 文献 · Blood · 2021-01-01

肝素诱导的血小板减少症(HIT)由含血小板因子4/肝素抗原的超大免疫复合物(ULIC)介导,属促血栓性疾病。本研究发现HIT ULIC在缓冲液和血浆中与C1q物理结合,经经典途径激活补体,促进IgG与C3片段在中性粒细胞和单核细胞表面共沉积;补体激活进而促进单核细胞组织因子表达、增强IgG与FcγR结合及血小板黏附,抑制补体近端而非末端步骤可消除该组织因子表达。

要点

  • HIT ULIC经经典途径激活补体,促进C3片段与IgG在白细胞表面共沉积。
  • 补体激活促进单核细胞组织因子表达,该效应不依赖FcγR。
  • 抑制补体近端步骤可消除HIT ULIC诱导的单核细胞组织因子表达。

核心结论

  • 补体激活在调控HIT ULIC的Fc依赖性效应功能中起主要作用。
  • 补体通路近端步骤是HIT潜在的非抗凝治疗靶点。

研究设计与样本

  • 基础实验研究,检测HIT ULIC与C1q在缓冲液和血浆中的物理结合及补体激活。

主要发现

  • HIT ULIC在缓冲液和血浆中与C1q物理结合,经经典途径激活补体。
  • HIT ULIC促进IgG与C3c在中性粒细胞和单核细胞表面共沉积。
  • 补体激活促进FcγR非依赖性单核细胞组织因子表达,增强IgG与细胞表面FcγR结合,并促进血小板黏附于受损内皮。
  • 抑制补体近端而非末端步骤可消除HIT ULIC诱导的单核细胞组织因子表达。

临床怎么用

  • 提示补体近端通路抑制可能作为HIT的非抗凝治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder mediated by ultra-large immune complexes (ULICs) containing immunoglobulin G (IgG) antibodies to a multivalent antigen composed of platelet factor 4 and heparin. The limitations of current antithrombotic therapy in HIT supports the need to identify additional pathways that may be targets for therapy. Activation of FcγRIIA by HIT ULICs initiates diverse procoagulant cellular effector functions. HIT ULICs are also known to activate complement, but the contribution of this pathway to the pathogenesis of HIT has not been studied in detail. We observed that HIT ULICs physically interact with C1q in buffer and plasma, activate complement via the classical pathway, promote codeposition of IgG and C3 complement fragments (C3c) on neutrophil and monocyte cell surfaces. Complement activation by ULICs, in turn, facilitates FcγR-independent monocyte tissue factor expression, enhances IgG binding to the cell surface FcγRs, and promotes platelet adhesion to injured endothelium. Inhibition of the proximal, but not terminal, steps in the complement pathway abrogates monocyte tissue factor expression by HIT ULICs. Together, these studies suggest a major role for complement activation in regulating Fc-dependent effector functions of HIT ULICs, identify potential non-anticoagulant targets for therapy, and provide insights into the broader roles of complement in immune complex-mediated thrombotic disorders.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Khandelwal S, Barnes A, Rauova L, et al. Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes. Blood. 2021. PMID: 34189574. doi:10.1182/blood.2020009487

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。